Back to companies

Precision Biosciences Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Precision Biosciences Inc (Precision BioSciences) is a clinical-stage gene editing company. It utilizes its novel proprietary ARCUS genome editing platform to develop in vivo gene editing therapies for genetic and infectious diseases. Precision BioSciences product pipeline includes PBGENE-HBV, which treats chronic hepatitis B; PBGENE-DMD that targets duchenne muscular dystrophy; PBGENE-3243 for m3243 mitochondrial myopathy; PBGENE-ALS which treats C9orf72 amyotrophic lateral sclerosis; ECURE-OTC for omithine transcarbamylase deficiency; and PBGENE-LIVER. The company leverages ARCUS, a proprietary genome editing technology to make highly specific cuts and DNA insertions in cellular DNA. Precision BioSciences is headquartered in Durham, North Carolina, the US.

 Gain a 360-degree view of Precision Biosciences Inc and make more informed decisions for your business Gain a 360-degree view of Precision Biosciences Inc and make more informed decisions for your business Register your interest
Headquarters United States of America
Address Suite A-100, 302 East Pettigrew Street, Durham, North Carolina, 27701
Website www.precisionbiosciences.com/
Telephone 1 919 3145512
No of Employees 68
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange DTIL (NASD)
Revenue (2024) $34.3M -50.1% (2024 vs 2023)
EPS XYZ
Net Income (2024) XYZ -738% (2024 vs 2023)
Market Cap* $188.9M
Net Profit Margin (2024) XYZ -1,379.5% (2024 vs 2023)
* As of and is in US$
View Precision Biosciences Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Products and Services

Products
Pipeline
PBGENE-HBV: Chronic Hepatitis B
PBGENE-DMD: Duchenne Muscular Dystrophy
XYZ
XYZ
XYZ
Understand Precision Biosciences Inc portfolio and identify potential areas for collaboration Understand Precision Biosciences Inc portfolio and identify potential areas for collaboration Register your interest
Image for loader

Competitor Comparison

Key Parameters Precision Biosciences Inc Intellia Therapeutics Inc Editas Medicine Inc Caribou Biosciences Inc Prime Medicine Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Durham Cambridge Cambridge Berkeley Cambridge
State/Province North Carolina Massachusetts Massachusetts California Massachusetts
No. of Employees 68 377 87 97 146
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
Kevin J.Buehler Chairman Executive Board 2019 68
Michael Amoroso Chief Executive Officer; Director; President Executive Board 2021 48
Alex Kelly Chief Financial Officer Senior Management 2021 59
Juli Blanche Chief People Officer Senior Management - -
Cassie Gorsuch, PhD Chief Scientific Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Precision Biosciences Inc key executives to enhance your sales strategy Gain insight into Precision Biosciences Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?